![Aneesh Karatt-Vellatt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aneesh Karatt-Vellatt
Fondatore presso Maxion Therapeutics Ltd.
Posizioni attive di Aneesh Karatt-Vellatt
Società | Posizione | Inizio | Fine |
---|---|---|---|
Maxion Therapeutics Ltd.
![]() Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Direttore/Membro del Consiglio | 31/05/2022 | - |
Direttore Tecnico/Scientifico/R&S | - | - | |
Fondatore | 16/04/2020 | - |
Storia della carriera di Aneesh Karatt-Vellatt
Statistiche
Distribuzione geografica
Regno Unito | 2 |
Posizioni
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Maxion Therapeutics Ltd.
![]() Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Health Technology |